| Business Type: |
Manufacturer |
| Year Established: |
2015 |
| Industry Focus: |
Pharmaceutical Intermediates |
| Products/Services We Offer: |
Abiraterone Acetate
Actinomycin D
Adefovir
Afatinib
Avanafil
Axitinib
Azelnidipine
Azilsartan Medoxomil
Bortezomib
Brivaracetam
Canagliflozin
Canagliflozin HemiHydrate
Carboplatin
Carubicin
Cediranib
Cisplatin
Crizotinib
Dalbavancin
***etaxel
***etaxel TriHydrate
Doxorubicin hydrochloride
Eprosartan
Erlotinib
Erlotinib Hydrochloride
Everolimus
Fluoxetine Hydrochloride
Gefitinib Hydrochloride
Irinotecan Hydrochloride TriHydrate
Lenalidomide
Methotrexate
Mildronate
MMAE
Oxalipl |
| Main Markets: |
Mainland China Hong Kong,Macao and Taiwan North America South America Western Europe Eastern Europe |
| Other Markets: |
|
| OEM Service: |
Yes |
| R&D Staff: |
11 - 50 People |
| Legal Representative / CEO: |
|
| Number of Employees: |
11 - 50 People |
| Annual Turnover: |
US$5 Million - US$10 Million |
| Certificate: |
SGS |
Home
